Successful Treatment of Kasabach-Merritt Syndrome with Prednisone and Epsilon-Aminocaproic Acid

References

• Wallerstein RO. Spontaneous involution of giant hemangioma. Am J Dis Child. 1961; 102: 233–235
   PubMedGoogle Scholar
• Kissinger CC, Sternfield E, Zucker SD. Rupture of cavernous hemangioma of the liver as a cause of death in newborn infants. Ohio Med J. 1940; 36: 383–389
   Google Scholar
• Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura (report of a case). Am J Dis Child. 1940; 59: 1063–1070
   Google Scholar
• Kontras SB, Green OC, King L, et al. Giant hemangioma with thrombocytopenia. Am J Dis Child. 1963; 105: 188–195
   PubMedGoogle Scholar
• Hillman RS, Phillips LL. Clotting-fibrinolysis in a cavernous hemangioma. Am J Dis Child. 1967; 113: 649–653
   PubMedGoogle Scholar
• Straub PW, Kessler S, Schreiber A, Frick PG. Chronic intravascular coagulation in Kasabach-Merritt syndrome. Arch Intern Med. 1972; 129: 475–479
   PubMedGoogle Scholar
• Schmidt RP, Lentle BC. Hemangioma with consumptive coagulopathy (Kasabach-Merritt syndrome). Detection by Indium-111 Oxine-labeled platelets. Clin Nucl Med. 1984; 7: 389–391
   Google Scholar
• Warrel RP, Jr, Kempin SJ. Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med. 1985; 313: 308–312
   Google Scholar
• Martins AG. Hemangioma and thrombocytopenia. J Pediar Surg. 1970; 5: 641–648
   PubMedGoogle Scholar
• Margileth AM. Treatment of giant hemangioma. J Pediatr. 1978; 92: 1030–1031
   PubMedGoogle Scholar
• Stanley P, Gomperts E, Woolley MM. Kasabach-Merritt syndrome treated by therapeutic embolization with polyvinyl alcohol. Am J Pediatr Hematol Oncol. 1986; 8: 308–311
   PubMedGoogle Scholar
• Pochard J, Brunelle F, Didier F, Hubert C. Syndrome de Kasabach-Merritt à localisation pancréatique chez un nouveau-né [Kasabach-Merritt syndrome with pancreatic involvement in a neonate]. Arch Fr Pediatr. 1989; 46: 443–446
   PubMedGoogle Scholar
• Evans J, Batchelor ADR, Stark G, Uttley WS. Haemangioma with coagulopathy: sustained response to prednisone. Arch Dis Child. 1975; 50: 809–812
   PubMedGoogle Scholar
• Brown SH, Neerhout RC, Fonkalsrud EW. Prednisone therapy in the management of large hemangiomas in infants and children. Surgery 1972; 71(2)168–173
   PubMedGoogle Scholar
• Sadan N, Horowitz I, Choc L, Pikielny S, Wolach B. Giant hemangioma with thrombocytopenia and osteolysis successfully treated with prednisone. J Pediatr Orthop. 1989; 9(4)472–475
   PubMedGoogle Scholar
• Zweifach BW, Sharr E, Black MM. The influence of the adrenal cortex on behavior of terminal vascular bed. Ann NY Acad Sci. 1953; 56: 626–633
   PubMed Web of Science ®Google Scholar
• Kitchens CS. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest. 1977; 60: 1129–1134
   PubMed Web of Science ®Google Scholar
• Laug WE. Glucocorticosteroids inhibit plasminogen activator production by endothelial cells. Thromb Haemost. 1982; 50(4)888–892
   Google Scholar
• Coleman PL, Patel PD, Cwikel BJ, Rafferty UM, Sznycer-Laszuk R, Gelehrter TD. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells. J Biol Chem. 1986; 261: 4352–4357
   PubMedGoogle Scholar
• Koerper MA, Addiego JE, de Lorimier AA, Lipow H, Price D, Lubin BH. Use of aspirin and dipyridamole in children with platelet trapping syndromes. J. Pediatr. 1983; 102: 311–314
   PubMedGoogle Scholar
• Rodriguez-Erdmann F, Button L, Murray JE, et al. Kasabach-Merritt syndrome: coagulo-analytical observations. Am J Med Sci. 1971; 26: 9–15
   Google Scholar
• Hurvitz CH, Alkalay AL, Sloninsky L, Kallus M, Pomerance JJ. Cyclophosphamide therapy in life-threatening vascular tumors. J Pediatr. 1986; 109: 360–363
   PubMedGoogle Scholar
• Orchard PJ, Smith CM, Woods WE. Treatment of haemangio-endothelioma with alpha interferon. Lancet Sept, 1989; 565–567
   PubMedGoogle Scholar
• Hanna BD, Bernstein M. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. Am J Pediatr Hematol Oncol. 1989; 11(2)191–193
   PubMedGoogle Scholar
• Neidhart JA, Roach RW. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid: is fibrinolysis “defensive”?. Am J Med. 1983; 72: 434–438
   Google Scholar
• Henriksson P, Nilsson IM, Bergentz SE, Ljungqvist U, Rosengren B. Giant hemangioma with a disorder of coagulation. Acta Paediatr Scand. 1971; 60: 227–234
   PubMedGoogle Scholar
• Ortel TL, Onorato JJ, Bedrosian LL, Kaufman RE. Antifibrinolytic therapy in the management of the Kasabach-Merritt syndrome. Am J Hematol. 1988; 29: 44–48
   PubMedGoogle Scholar